Skip to main content

Table 2 Description of bleeding sites (n = 686)

From: Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice

Site

Number (percentage)

Intracranial

300 (43.7)

Gastrointestinal

167 (24.3)

Deep muscle hematoma or neural compression syndrome or both

65 (9.5)

Hemoperitoneum/Hemoretroperitoneum

59 (8.6)

Hemothorax

26 (3.8)

Hematuria

22 (3.2)

Hemoptysis

17 (2.5)

Hemopericardium

6 (0.9)

Hemarthrosis

6 (0.9)

Intraocular or retro-orbital

4 (0.6)

Intraspinal

2 (0.3)

Unknown

37 (5.4)

  1. Multiple sites of bleeding were observed in several patients: 22 patients with two sites, four patients with three sites, and one patient with four sites.